Nabla, a burgeoning French startup, is revolutionizing the healthcare sector by introducing an AI copilot designed to accelerate and enhance the interaction between doctors and their patients. Nabla’s innovative technology, which has recently garnered $24 million in a series B funding round from Cathay Innovation and Zebox, is poised to transform the traditional healthcare model. This latest influx of capital propels the company’s total investment to a significant $44.6 million.
The realm of healthcare has seen various iterations of copilots, yet their integration has been sluggish, primarily due to the reservations held by medical professionals. However, Nabla’s offering seems to have overcome these barriers, providing a seamless, efficient, and intelligent assistant that works alongside doctors, enhancing their capabilities and productivity.
At the heart of Nabla’s solution is the AI copilot, a sophisticated tool that integrates as a web app or a Chrome extension on a doctor’s computer. It operates by attentively listening to the doctor-patient consultations, and through the prowess of artificial intelligence, it instantly generates clinical notes. This not only alleviates the burdensome task of manual documentation but ensures that all critical information from the patient’s medical history to prescribed medications and tests is accurately captured and easily accessible.
These notes are comprehensive and include all the vital details of the consultation. Physicians can then review and edit these notes before seamlessly integrating them into the patient’s electronic health record. Furthermore, Nabla is on the cusp of introducing a feature that will automatically generate patient instructions based on the consultation, thereby further simplifying the process for healthcare providers.
The technological backbone of Nabla’s copilot comprises a real-time speech-to-text AI that utilizes a blend of Microsoft’s speech-to-text API and the Whisper model, finely tuned for medical consultations. This model effectively transcribes the conversation, which is then distilled into a succinct clinical note by leveraging the GPT series of large language models (LLMs). Notably, the system is designed to ensure privacy and security; all personally identifiable information is masked during processing and only revealed in the final note with appropriate consent.
In less than a year since its launch, Nabla’s impact is undeniable. Physicians, who traditionally spent up to 40% of their day on documentation, now see a dramatic reduction in this time-consuming task. The copilot has been swiftly adopted by over 20,000 providers and is on track to facilitate three million consultations. Testimonials from healthcare professionals like M. Tursich, a psychologist from Houston, underscore the transformative effect of Nabla, with many reclaiming valuable time and being able to focus more on patient care rather than administrative duties.
The company prides itself on the accuracy and reliability of its AI-generated notes, which require minimal adjustments. As Nabla continues to refine its models, the precision and utility of its copilot are expected to further advance. The recent funding will fuel Nabla’s expansion into the U.S. market and enhance its offerings, including adding more language options to cater to a diverse population.
Currently, Nabla Copilot is accessible via any email and supports English, Spanish, and French, making it versatile and user-friendly. As Nabla continues on its mission to build the most intuitive and reliable ambient AI for the medical field, it is set to pave the way for an AI-driven future in healthcare, promising increased efficiency, accuracy, and improved patient outcomes. This represents not just a technological advancement but a significant leap forward in the way healthcare is delivered and experienced by both providers and patients.